Alnylam Pharmaceuticals reported $-191686000 in EBIT for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebit Change
Acadia Pharmaceuticals ACAD:US $ -33651000 79.36M
Agios Pharmaceuticals AGIO:US $ -97640000 3.5M
Alnylam Pharmaceuticals ALNY:US $ -191686000 44.95M
Amgen AMGN:US $ 2176M 324M
Arrowhead Research ARWR:US $ -72909000 114.46M
Biocryst Pharmaceuticals BCRX:US $ -34722000 15.24M
Biomarin Pharmaceutical BMRN:US $ 39.15M 9.82M
Bluebird Bio BLUE:US $ -100761000 19.58M
Intercept Pharmaceuticals ICPT:US $ -13363000 3.09M
IONIS PHARMACEUT IONS:US $ -85514000 28.01M
Mirati Therapeutics MRTX:US $ -177205000 7.01M
Moderna Inc MRNA:US 2.45B 1.78B
Neurocrine Biosciences NBIX:US $ 54.7M 51.6M
Novartis NVS:US 3.32B 176M
Ptc Therapeutics PTCT:US $ -92362000 5.84M
Regeneron Pharmaceuticals REGN:US $ 1306.9M 20.3M
Regulus Therapeutics RGLS:US $ -6569000 391K
Sangamo Biosciences SGMO:US $ -45734000 473K
Sarepta Therapeutics SRPT:US $ -211132000 124.25M
Takeda 4502:JP 150.52B 152.13B
Ultragenyx Pharmaceutical RARE:US $ -141593000 4.96M
Vertex Pharmaceuticals VRTX:US $ 1119.3M 85.9M
Xencor XNCR:US $ -28000000 54.47M
YTE INCY:US $ 260.29M 132.62M